Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147)
- PMID: 1724616
Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147)
Erratum in
-
Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147).Pept Res. 1991 May-Jun;4(3):199. Pept Res. 1991. PMID: 1823191 No abstract available.
Abstract
B and T cell epitopes expressed on the surface of S-protein, a major constituent of the envelope of hepatitis B virus (HBV), are essential for eliciting protective immunity against HBV infection. A segment of the S-protein sequence encompassing residues S(139-147) is a portion of overlapping B and T cell epitopes. This sequence is conserved among distinct serological subtypes of HBV and has a 77.8% homology with an analogous sequence in S-proteins of nonhuman mammalian hepadnaviruses. Rare subtypes and variants of HBV having amino acid replacements within the S(139-147) sequence were discerned recently. The impact of amino acid replacements within this sequence on its immunological recognition at both the B and T cell levels was explored by peptide replacement set analysis. Results of the analysis permit discrimination between tolerated and forbidden amino acid replacements and provide a background for the development of reagents and immunogens specific for emerging HBV variants.
Similar articles
-
Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S(122-136).Pept Res. 1992 Jul-Aug;5(4):217-26. Pept Res. 1992. PMID: 1384823
-
Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.Mol Immunol. 2006 Feb;43(5):436-42. doi: 10.1016/j.molimm.2005.03.002. Epub 2005 Apr 2. Mol Immunol. 2006. PMID: 16337486
-
Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.Biochemistry (Mosc). 1998 May;63(5):551-8. Biochemistry (Mosc). 1998. PMID: 9632891
-
In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.J Immunol. 1993 Sep 15;151(6):3353-60. J Immunol. 1993. PMID: 7690803
-
Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147).Pept Res. 1991 May-Jun;4(3):199. Pept Res. 1991. PMID: 1823191 No abstract available.
Cited by
-
Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains.J Exp Med. 1993 Jan 1;177(1):127-34. doi: 10.1084/jem.177.1.127. J Exp Med. 1993. PMID: 7678109 Free PMC article.
-
Normal HBsAg presentation and T-cell defect in the immune response of nonresponders.Immunogenetics. 1995;41(6):366-74. doi: 10.1007/BF00163994. Immunogenetics. 1995. PMID: 7759133
-
Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide.Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11900-4. doi: 10.1073/pnas.89.24.11900. Proc Natl Acad Sci U S A. 1992. PMID: 1361231 Free PMC article.
-
Hepatitis B virus S gene escape mutants.Asian J Transfus Sci. 2007 Jul;1(2):62-70. doi: 10.4103/0973-6247.33445. Asian J Transfus Sci. 2007. PMID: 21938236 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources